Bionomics Limited (Nasdaq: BNOX) (ASX: BNO) shares have kicked into rally mode, surging by over 65% since August 22nd to score an intra-week high thus far of $1.98. The rally is deserved, with the fuse lit after BNOX announced that the last patient visit had been completed in its Phase 2 ATTUNE study in Post-Traumatic Stress Disorder ("PTSD"
View the full press: https://marketwirenews.com/articles/bionomics...n4754.html